Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Folate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenografts.

He ZY, Wei XW, Luo M, Luo ST, Yang Y, Yu YY, Chen Y, Ma CC, Liang X, Guo FC, Ye TH, Shi HS, Shen GB, Wang W, Gong FM, He G, Yang L, Zhao X, Song XR, Wei YQ.

J Control Release. 2013 Dec 28;172(3):679-89. doi: 10.1016/j.jconrel.2013.10.015.

PMID:
24144916
2.

Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3.

Sun C, Yi T, Song X, Li S, Qi X, Chen X, Lin H, He X, Li Z, Wei Y, Zhao X.

Oncol Rep. 2011 Jul;26(1):193-200. doi: 10.3892/or.2011.1275.

PMID:
21519794
3.

Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.

Liu L, Gou M, Yi T, Bai Y, Wei Y, Zhao X.

Oncol Rep. 2014 Apr;31(4):1623-8. doi: 10.3892/or.2014.2995.

PMID:
24482188
4.

Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.

Huang YH, Bao Y, Peng W, Goldberg M, Love K, Bumcrot DA, Cole G, Langer R, Anderson DG, Sawicki JA.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3426-30. doi: 10.1073/pnas.0813348106.

5.

Folate-Modified Lipoplexes Delivering the Interleukin-12 Gene for Targeting Colon Cancer Immunogene Therapy.

Luo M, Liang X, Luo ST, Wei XW, Liu T, Ren J, Ma CC, Yang YH, Wang BL, Liu L, Song XR, He ZY, Wei YQ.

J Biomed Nanotechnol. 2015 Nov;11(11):2011-23.

PMID:
26554159
6.

Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha.

He Z, Yu Y, Zhang Y, Yan Y, Zheng Y, He J, Xie Y, He G, Wei Y, Song X.

J Biomed Nanotechnol. 2013 May;9(5):833-44.

PMID:
23802413
7.

Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex.

He ZY, Deng F, Wei XW, Ma CC, Luo M, Zhang P, Sang YX, Liang X, Liu L, Qin HX, Shen YL, Liu T, Liu YT, Wang W, Wen YJ, Zhao X, Zhang XN, Qian ZY, Wei YQ.

Sci Rep. 2016 Mar 30;6:23764. doi: 10.1038/srep23764.

8.

VEGF-targeted short hairpin RNA inhibits intraperitoneal ovarian cancer growth in nude mice.

Bai Y, Deng H, Yang Y, Zhao X, Wei Y, Xie G, Li Z, Chen X, Chen L, Wang Y, Su D, Qian Z, Zhong Q, Luo H, Yi T.

Oncology. 2009;77(6):385-94. doi: 10.1159/000279385.

PMID:
20130421
9.

Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.

Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.

Eur J Pharm Biopharm. 2008 Nov;70(3):718-25. doi: 10.1016/j.ejpb.2008.06.026.

PMID:
18647651
10.

[Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].

Chen Y, Zhang L, Wu HJ, Liu WX, Hao Q.

Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):324-30. Chinese.

PMID:
21875458
11.

RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.

Zhang X, Deng HX, Zhao X, Su D, Chen XC, Chen LJ, Wei YQ, Zhong Q, Li ZY, He X, Yi T.

Oncology. 2009;77(1):22-32. doi: 10.1159/000218201.

PMID:
19440000
13.

Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3.

Jiang Q, Dai L, Cheng L, Chen X, Li Y, Zhang S, Su X, Zhao X, Wei Y, Deng H.

J Obstet Gynaecol Res. 2013 Mar;39(3):701-9. doi: 10.1111/j.1447-0756.2012.02007.x.

PMID:
23003327
14.

Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.

Shang X, Lin X, Manorek G, Howell SB.

Mol Pharmacol. 2013 Jan;83(1):85-94. doi: 10.1124/mol.112.079798.

15.

Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy.

Wang D, Saga Y, Mizukami H, Sato N, Nonaka H, Fujiwara H, Takei Y, Machida S, Takikawa O, Ozawa K, Suzuki M.

Int J Oncol. 2012 Apr;40(4):929-34. doi: 10.3892/ijo.2011.1295.

16.

Paradoxical impact of two folate receptors, FRĪ± and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.

Siu MK, Kong DS, Chan HY, Wong ES, Ip PP, Jiang L, Ngan HY, Le XF, Cheung AN.

PLoS One. 2012;7(11):e47201. doi: 10.1371/journal.pone.0047201.

17.

Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.

Zou L, Song X, Yi T, Li S, Deng H, Chen X, Li Z, Bai Y, Zhong Q, Wei Y, Zhao X.

Cancer Gene Ther. 2013 Apr;20(4):242-50. doi: 10.1038/cgt.2013.12.

PMID:
23492823
18.

Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.

Su D, Deng H, Zhao X, Zhang X, Chen L, Chen X, Li Z, Bai Y, Wang Y, Zhong Q, Yi T, Qian Z, Wei Y.

Cytotherapy. 2009;11(5):642-52. doi: 10.1080/14653240902878308.

PMID:
19593703
19.

A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.

Zhao X, Li DC, Zhao H, Li Z, Wang JX, Zhu DM, Zhou J, Cen JN.

Oncol Rep. 2012 Mar;27(3):628-36. doi: 10.3892/or.2011.1602.

PMID:
22200682
20.

Supplemental Content

Support Center